Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $149B |
| FY2017, ended Dec 30, 2017 | $170B |
| FY2018, ended Dec 29, 2018 | $155B |
| FY2019, ended Dec 28, 2019 | $191B |
| FY2020, ended Dec 26, 2020 | $200B |
| FY2021, ended Dec 25, 2021 | $235B |
| FY2022, ended Dec 31, 2022 | $249B |
| FY2023, ended Dec 30, 2023 | $233B |
| FY2024, ended Dec 28, 2024 | $210B |
| FY2025, ended Dec 27, 2025 | $196B |
| Trailing 12 months to Sep 5, 2026 (through Q3 FY2026) | $188B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $62.8B |
| FY2017, ended Dec 30, 2017 | $63.5B |
| FY2018, ended Dec 29, 2018 | $64.7B |
| FY2019, ended Dec 28, 2019 | $67.2B |
| FY2020, ended Dec 26, 2020 | $70.4B |
| FY2021, ended Dec 25, 2021 | $79.5B |
| FY2022, ended Dec 31, 2022 | $86.4B |
| FY2023, ended Dec 30, 2023 | $91.5B |
| FY2024, ended Dec 28, 2024 | $91.9B |
| FY2025, ended Dec 27, 2025 | $93.9B |
| Trailing 12 months to Sep 5, 2026 (through Q3 FY2026) | $98.2B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $6.33B | $7.62B |
| FY2017, ended Dec 30, 2017 | $4.86B | $7.06B |
| FY2018, ended Dec 29, 2018 | $12.5B | $6.13B |
| FY2019, ended Dec 28, 2019 | $7.31B | $5.42B |
| FY2020, ended Dec 26, 2020 | $7.12B | $6.37B |
| FY2021, ended Dec 25, 2021 | $7.62B | $6.99B |
| FY2022, ended Dec 31, 2022 | $8.91B | $5.60B |
| FY2023, ended Dec 30, 2023 | $9.07B | $7.92B |
| FY2024, ended Dec 28, 2024 | $9.58B | $7.19B |
| FY2025, ended Dec 27, 2025 | $8.24B | $7.67B |
| Trailing 12 months to Sep 5, 2026 (through Q3 FY2026) | $10.9B | $10.5B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $9.16B |
| FY2017, ended Dec 30, 2017 | $10.6B |
| FY2018, ended Dec 29, 2018 | $8.72B |
| FY2019, ended Dec 28, 2019 | $5.51B |
| FY2020, ended Dec 26, 2020 | $8.19B |
| FY2021, ended Dec 25, 2021 | $5.60B |
| FY2022, ended Dec 31, 2022 | $4.95B |
| FY2023, ended Dec 30, 2023 | $9.71B |
| FY2024, ended Dec 28, 2024 | $8.51B |
| FY2025, ended Dec 27, 2025 | $9.16B |
| Trailing 12 months to Sep 5, 2026 (through Q3 FY2026) | $10.7B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $41.3B |
| FY2017, ended Dec 30, 2017 | $43.3B |
| FY2018, ended Dec 29, 2018 | $36.3B |
| FY2019, ended Dec 28, 2019 | $34.9B |
| FY2020, ended Dec 26, 2020 | $47.5B |
| FY2021, ended Dec 25, 2021 | $44.2B |
| FY2022, ended Dec 31, 2022 | $42.2B |
| FY2023, ended Dec 30, 2023 | $48.0B |
| FY2024, ended Dec 28, 2024 | $48.3B |
| FY2025, ended Dec 27, 2025 | $53.2B |
| Trailing 12 months to Sep 5, 2026 (through Q3 FY2026) | $51.9B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 4.5% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.43B |
| FY2017, ended Dec 30, 2017 | 1.42B |
| FY2018, ended Dec 29, 2018 | 1.40B |
| FY2019, ended Dec 28, 2019 | 1.39B |
| FY2020, ended Dec 26, 2020 | 1.38B |
| FY2021, ended Dec 25, 2021 | 1.38B |
| FY2022, ended Dec 31, 2022 | 1.38B |
| FY2023, ended Dec 30, 2023 | 1.37B |
| FY2024, ended Dec 28, 2024 | 1.37B |
| FY2025, ended Dec 27, 2025 | 1.37B |
| Trailing 12 months to Sep 5, 2026 (through Q3 FY2026) | 1.36B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $3.00B | $284M |
| FY2017, ended Dec 30, 2017 | $2.00B | $292M |
| FY2018, ended Dec 29, 2018 | $2.00B | $256M |
| FY2019, ended Dec 28, 2019 | $3.00B | $237M |
| FY2020, ended Dec 26, 2020 | $2.00B | $264M |
| FY2021, ended Dec 25, 2021 | $106M | $301M |
| FY2022, ended Dec 31, 2022 | $1.50B | $343M |
| FY2023, ended Dec 30, 2023 | $1.00B | $380M |
| FY2024, ended Dec 28, 2024 | $1.00B | $362M |
| FY2025, ended Dec 27, 2025 | $1.00B | $288M |
| Trailing 12 months to Sep 5, 2026 (through Q3 FY2026) | $987M | $321M |
Valuation
At current price- Market Cap
- $182B
- P/E
- 16.7×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 1.9×
- Price / Book
- 8.2×
- EV / EBITDA
- 11.9×
Growth
Trailing 12 months- Revenue (TTM)
- $98.2B
- Revenue Growth YoY
- 6.4%
- Revenue CAGR 3Y
- 2.8%
- Revenue CAGR 5Y
- 5.9%
- EPS Growth YoY
- 51.1%
- Net Income Growth YoY
- 50.9%
Profitability
Trailing 12 months- Gross Margin
- 54.2%
- Operating Margin
- 15.3%
- Net Margin
- 11.1%
- FCF Margin
- 10.7%
- Return on Equity
- 52.3%
Earnings
Trailing 12 months- Net Income
- $10.9B
- EPS (diluted)
- $7.95
- EBITDA
- $18.7B
- Operating Income
- $15.1B
Balance Sheet
As of Sep 5, 2026- Cash and cash equivalents
- $10.7B
- Total Debt
- $51.9B
- Net Debt
- $41.2B
- Total Assets
- $112B
- Total Liabilities
- $89.5B
- Shareholders' Equity
- $22.3B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $14.6B
- Capital Expenditure
- $4.10B
- Free Cash Flow
- $10.5B
Dividends and risk
Last 12 months- Dividend Yield
- 4.3%
- Dividend / Share
- $5.81
- Beta (5Y)
- 0.36
Every ratio is calculated from the company’s reported figures.